TRICIDA INC's ticker is TCDA and the CUSIP is 89610F101. A total of 98 filers reported holding TRICIDA INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,849,000 | -18.3% | 427,975 | 0.0% | 0.06% | +26.0% |
| Q1 2021 | $2,264,000 | -25.0% | 427,975 | 0.0% | 0.05% | -30.6% |
| Q4 2020 | $3,017,000 | -54.3% | 427,975 | -41.2% | 0.07% | -71.7% |
| Q3 2020 | $6,595,000 | -72.5% | 727,975 | -16.5% | 0.25% | -72.2% |
| Q2 2020 | $23,966,000 | +24.1% | 872,137 | -0.7% | 0.91% | +1.9% |
| Q1 2020 | $19,315,000 | -44.8% | 877,975 | -5.4% | 0.90% | -35.8% |
| Q4 2019 | $35,022,000 | +4.8% | 927,975 | -14.3% | 1.40% | -31.3% |
| Q3 2019 | $33,429,000 | -28.1% | 1,082,880 | -8.1% | 2.04% | -23.8% |
| Q2 2019 | $46,483,000 | +19.2% | 1,177,975 | +16.7% | 2.67% | +1.3% |
| Q1 2019 | $38,990,000 | +126.0% | 1,009,586 | +38.0% | 2.64% | +88.1% |
| Q4 2018 | $17,252,000 | -23.1% | 731,621 | -0.4% | 1.40% | -4.0% |
| Q3 2018 | $22,442,000 | -19.7% | 734,588 | -21.4% | 1.46% | -29.4% |
| Q2 2018 | $27,944,000 | – | 934,588 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 9,614,280 | $362,843,000 | 5.18% |
| Redmile Group, LLC | 2,129,100 | $80,352,000 | 1.92% |
| Burrage Capital Management LLC | 70,653 | $2,666,000 | 1.79% |
| Avoro Capital Advisors LLC | 1,560,000 | $58,874,000 | 1.73% |
| Opaleye Management Inc. | 194,000 | $7,303,000 | 1.43% |
| Cormorant Asset Management, LP | 927,975 | $35,022,000 | 1.40% |
| Duquesne Family Office | 688,344 | $25,978,000 | 0.76% |
| H2O AM LLP | 67,991 | $2,566,000 | 0.61% |
| Artal Group S.A. | 360,000 | $13,586,000 | 0.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 37,000 | $1,393,000 | 0.50% |